- Home
- GLMD vs CELZ Comparison
GLMD vs CELZ Comparison
Compare GLMD & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- CELZ
- Stock Information
- Founded
- GLMD 2000
- CELZ 1998
- Country
- GLMD Israel
- CELZ United States
- Employees
- GLMD N/A
- CELZ N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- GLMD Health Care
- CELZ Health Care
- Exchange
- GLMD Nasdaq
- CELZ Nasdaq
- Market Cap
- GLMD 4.6M
- CELZ 4.7M
- IPO Year
- GLMD 2014
- CELZ N/A
- Fundamental
- Price
- GLMD $3.04
- CELZ $2.11
- Analyst Decision
- GLMD
- CELZ
- Analyst Count
- GLMD 0
- CELZ 0
- Target Price
- GLMD N/A
- CELZ N/A
- AVG Volume (30 Days)
- GLMD 45.4K
- CELZ 22.5K
- Earning Date
- GLMD 01-03-2025
- CELZ 11-08-2024
- Dividend Yield
- GLMD N/A
- CELZ N/A
- EPS Growth
- GLMD N/A
- CELZ N/A
- EPS
- GLMD N/A
- CELZ N/A
- Revenue
- GLMD N/A
- CELZ $11,000.00
- Revenue This Year
- GLMD N/A
- CELZ N/A
- Revenue Next Year
- GLMD N/A
- CELZ N/A
- P/E Ratio
- GLMD N/A
- CELZ N/A
- Revenue Growth
- GLMD N/A
- CELZ N/A
- 52 Week Low
- GLMD $2.56
- CELZ $1.96
- 52 Week High
- GLMD $23.80
- CELZ $10.28
- Technical
- Relative Strength Index (RSI)
- GLMD 49.68
- CELZ 35.78
- Support Level
- GLMD $2.81
- CELZ $1.96
- Resistance Level
- GLMD $3.35
- CELZ $2.50
- Average True Range (ATR)
- GLMD 0.26
- CELZ 0.20
- MACD
- GLMD 0.05
- CELZ 0.01
- Stochastic Oscillator
- GLMD 57.83
- CELZ 26.24
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.